Company: LPSN
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001102993-25-000053
Chunk: 116

Company: LIVEPERSON INC
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 8
Chunk 116
---
, valuation allowance recorded against losses generated in the U.S. and Germany, a tax benefit related to an increase in tax receivables, and changes to unrecognized tax benefits in Israel. The overall tax provision recorded represents tax on non-U.S. earnings in the various jurisdictions in which we operate and the provision for U.S. state and local impacts. The total tax expense associated with non-U.S. jurisdictions is relatively consistent between periods.

35

Liquidity and Capital Resources

The following describes the Company’s cash flows for the three months ended March 31, 2025 and 2024:

Three Months Ended March 31,20252024(In thousands)Condensed Consolidated Statements of Cash Flows Data:Net cash (used in) provided by operating activities$(3,096)$1,099 Net cash used in investing activities(4,145)(12,710)Net cash used in financing activities$(26)$(72,697)

As of March 31, 2025, we had approximately $176.3 million in cash and cash equivalents, a decrease of $7.0 million from December 31, 2024. The decrease is primarily attributable to various uses of cash for operating purposes, and purchases of property and equipment, including capitalized software.

Cash Flows from Operating Activities

Net cash used in operating activities was $3.1 million for the three months ended March 31, 2025. Our net loss of $14.1 million includes the effect of non-cash expenses of depreciation and amortization of $5.8 million, stock-based compensation of $4.7 million, interest expense of $5.7 million, and amortization of debt issuance costs and accretion of debt discount of $1.8 million, partially offset by a gain from the change in the fair value of our Warrants of $8.8 million. This was further driven by a decrease in accounts payable, accrued expenses and other current liabilities of $5.9 million, partially offset by a decrease in prepaid expenses and other current assets of $3.6 million, a decrease in contract acquisition costs of $1.7 million, and an increase in deferred revenue of $3.2 million.

Net cash provided by operating activities was $1.1 million for the three months ended March 31, 2024. Our net loss of $35.6 million includes the effect of non-cash expenses related to depreciation of $8.2 million, a net expense in stock-based compensation of